Internal Medicine, Rheumatology · El Paso, TX
NPI
1619463361
Since 2018
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4801 Alberta Ave
El Paso, TX, 79905
Phone (915) 215-5200
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
247 services
Medicare patients, 2024
71
Average age 68
Drug cost, 2024
$6.7M
3,623 prescriptions
Company payments, 2025
$33.36
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shrilekha Sairam was code 99214 (office e&m - established), 107 times for 63 patients. In total Shrilekha Sairam billed 247 services in 15 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 107 | 63 | $83.66 | $8,951 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 99 | 60 | $11.55 | $1,144 |
By year: 2022 $7,713 for 108 services; 2023 $10K for 127 services; 2024 $12K for 247 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shrilekha Sairam prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 702 prescriptions and refills. In total Shrilekha Sairam wrote 3,623 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 702 | 1,856 | 219 | $10K |
| Hydroxychloroquine Sulfate Generic | 420 | 1,154 | 145 | $13K |
| Enbrel Sureclick Etanercept | 302 | 323 | 41 | $2.4M |
| Prednisone Generic | 222 | 592 | 94 | $1,163 |
| Alendronate Sodium Generic | 188 | 526 | 66 | $1,115 |
| Humira(Cf) Pen Adalimumab | 164 | 170 | 24 | $1.3M |
| Folic Acid Generic | 158 | 468 | 59 | $1,473 |
| Celecoxib Generic | 140 | 330 | 71 | $3,837 |
| Leflunomide Generic | 95 | 265 | 32 | $6,705 |
| Pilocarpine Hcl Generic | 79 | 172 | 29 | $5,119 |
| Allopurinol Generic | 77 | 229 | 25 | $584 |
| Enbrel Etanercept | 68 | 73 | Under 11 | $477K |
| Rinvoq Upadacitinib | 64 | 72 | Under 11 | $466K |
| Humira Pen Adalimumab | 63 | 63 | Under 11 | $454K |
| Sulfasalazine Generic | 55 | 135 | 18 | $1,356 |
Brand drugs: 1,002 claims; generic drugs: 2,621 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shrilekha Sairam $33.36 ($33.36 in general payments such as food, travel and fees) from 1 company. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $33.36.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.